Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China.
Drug Des Devel Ther. 2021 May 4;15:1883-1902. doi: 10.2147/DDDT.S301417. eCollection 2021.
Rhubarb, as a traditional Chinese medicine, is the preferred drug for the treatment of stagnation and constipation in clinical practice. It has been reported that rhubarb possesses hepatotoxicity, but its mechanism in vivo is still unclear.
In this study, the chemical components in rhubarb were identified based on UPLC-Q-TOF/MS combined with data postprocessing technology. The metabolic biomarkers obtained through metabolomics technology were related to rhubarb-induced hepatotoxicity. Furthermore, the potential targets of rhubarb-induced hepatotoxicity were obtained by network pharmacology involving the above components and metabolites. Meanwhile, GO gene enrichment analysis and KEGG pathway analysis were performed on the common targets.
Twenty-eight components in rhubarb were identified based on UPLC-Q-TOF/MS, and 242 targets related to rhubarb ingredients were predicted. Nine metabolic biomarkers obtained through metabolomics technology were closely related to rhubarb-induced hepatotoxicity, and 282 targets of metabolites were predicted. Among them, the levels of 4 metabolites, namely dynorphin B (10-13), cervonoyl ethanolamide, lysoPE (18:2), and 3-hydroxyphenyl 2-hydroxybenzoate, significantly increased, while the levels of 5 metabolites, namely dopamine, biopterin, choline, coenzyme Q9 and P1, P4-bis (5'-uridyl) tetraphosphate significantly decreased. In addition, 166 potential targets of rhubarb-induced hepatotoxicity were obtained by network pharmacology. The KEGG pathway analysis was performed on the common targets to obtain 46 associated signaling pathways.
These data suggested that rhubarb may cause liver toxicity due to its action on dopamine D1 receptor (DRD1), dopamine D2 receptor (DRD2), phosphodiesterase 4B (PDE4B), vanilloid receptor (TRPV1); transient receptor potential cation channel subfamily M member 8 (TRPM8), prostanoid EP2 receptor (PTGER2), acetylcholinesterase (ACHE), muscarinic acetylcholine receptor M3 (CHRM3) through the cAMP signaling pathway, cholinergic synapses, and inflammatory mediators to regulate TRP channels. Metabolomics technology and network pharmacology were integrated to explore rhubarb hepatotoxicity to promote the reasonable clinical application of rhubarb.
大黄作为一种传统中药,是临床治疗积滞便秘的首选药物。已有报道称大黄具有肝毒性,但体内机制尚不清楚。
本研究采用 UPLC-Q-TOF/MS 结合数据后处理技术鉴定大黄中的化学成分,通过代谢组学技术获得与大黄致肝毒性相关的代谢标志物,再运用网络药理学技术获得大黄致肝毒性的潜在靶点,同时对上述成分及代谢物的共同靶点进行 GO 基因富集分析和 KEGG 通路分析。
基于 UPLC-Q-TOF/MS 鉴定出大黄中的 28 种成分,预测出与大黄成分相关的 242 个靶点。通过代谢组学技术获得的 9 个代谢标志物与大黄致肝毒性密切相关,预测出代谢物的 282 个靶点。其中,dynorphin B (10-13)、cervonoyl ethanolamide、lysoPE (18:2) 和 3-羟基苯 2-羟基苯甲酸等 4 种代谢物的水平显著升高,而多巴胺、生物蝶呤、胆碱、辅酶 Q9 和 P1、P4-双(5'-尿苷)四磷酸盐等 5 种代谢物的水平显著降低。此外,通过网络药理学获得 166 个大黄致肝毒性的潜在靶点,对共同靶点进行 KEGG 通路分析,获得 46 个相关信号通路。
这些数据提示,大黄可能通过作用于多巴胺 D1 受体(DRD1)、多巴胺 D2 受体(DRD2)、磷酸二酯酶 4B(PDE4B)、香草酸受体(TRPV1)、瞬时受体电位阳离子通道亚家族 M 成员 8(TRPM8)、前列腺素 EP2 受体(PTGER2)、乙酰胆碱酯酶(ACHE)、毒蕈碱乙酰胆碱受体 M3(CHRM3),通过 cAMP 信号通路、胆碱能突触和炎症介质调节 TRP 通道,导致肝毒性。本研究采用代谢组学技术和网络药理学相结合的方法探讨大黄肝毒性,促进大黄的合理临床应用。